Anavex Life Sciences
AVXL
#8093
Rank
โ‚น29.19 B
Marketcap
โ‚น315.00
Share price
-0.60%
Change (1 day)
-58.17%
Change (1 year)

Market capitalization of Anavex Life Sciences (AVXL)

Market cap: โ‚น29.19 Billion

As of May 2026 Anavex Life Sciences has a market cap of โ‚น29.19 Billion. This makes Anavex Life Sciences the world's 8093th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Anavex Life Sciences from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น29.19 B-0.01%
2025โ‚น29.19 B-66.87%
2024โ‚น88.11 B38.5%
2023โ‚น63.62 B6.5%
2022โ‚น59.73 B-39.11%
2021โ‚น98.11 B271%
2020โ‚น26.44 B150.84%
2019โ‚น10.54 B106.13%
2018โ‚น5.11 B-43.75%
2017โ‚น9.09 B-14.71%
2016โ‚น10.65 B-16.9%
2015โ‚น12.82 B1896.21%
2014โ‚น0.64 B10.53%
2013โ‚น0.58 B-55.56%
2012โ‚น1.30 B-25.45%
2011โ‚น1.75 B-57.31%
2010โ‚น4.10 B96.05%
2009โ‚น2.09 B-15.24%
2008โ‚น2.47 B-39.15%
2007โ‚น4.06 B77%
2006โ‚น2.29 B

End of Day market cap according to different sources

On May 3rd, 2026 the market cap of Anavex Life Sciences was reported to be:

โ‚น29.19 Billion
by Nasdaq info icon info icon
โ‚น29.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น261.74 B 796.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น523.76 B 1,694.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น3.40 B-88.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น221.56 B 659.01%๐Ÿ‡บ๐Ÿ‡ธ USA